Stay updated on Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.

Latest updates to the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has been updated to reflect a new study on the effects of benralizumab treatment on dendritic cells in patients with severe eosinophilic asthma, including details about the study's design and inclusion criteria. The previous version's information about the mechanisms of benralizumab and its clinical benefits has been removed.SummaryDifference48%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check96 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check103 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab Effect on Dendritic Cells in Eosinophilic Asthma Clinical Trial page.